Mörfelden-Walldorf, 11th of June 2024 – The Cansativa Group, the leading import and distribution platform of medical cannabis in Germany, has established an exclusive partnership with the most globally recognized cannabis brand, Cookies. As the sole licensee for Cookies products in Germany, Cansativa will import a premium selection of cannabis products for the medical cannabis market. The products are cultivated and supplied exclusively by RPK Biopharma, a 100% subsidiary of SOMAÍ Group.
The collaboration between Cansativa and Cookies marks a significant milestone in the German medical cannabis industry, as patients gain access to a range of high-quality products meticulously crafted to meet stringent quality, efficacy, and safety standards.
The Cookies product line available in Germany includes four dried cannabis flower varieties: Apples and Bananas, Medellín, Blanco, and Hawaiian Rain. The first product Apples and Bananas will be available nationwide in pharmacies by prescription from 1st of August 2024 and adhere to EU-GMP and GACP standards. Leveraging a meticulous selection process for cannabis genetics and a state-of-the-art cultivator, Cookies stands for reliable and superior products for both recreational and medical cannabis uses.
Patients can find detailed information about THC content and therapeutic applications of Cookies products at their doctor’s office or local pharmacy.
“We are thrilled about our collaboration with Cookies, which allows Cansativa to broaden the spectrum of top-tier cannabis varieties in the medical market in Germany,” says Benedikt Sons, Co-founder, managing director, and CEO of Cansativa. “Internationally, Cookies stands for high-quality cannabis products made with scientific precision and years of expertise. For patients in Germany who use medical cannabis for therapeutic purposes, Cookies offers a unique new range of medical cannabis varieties.”
“Germany is an exciting market for me for multiple reasons, the energy and vibe around legalization is contagious. Also, in the early 2000’s, I had my music randomly break on a radio station and took a trip to Germany and experienced the culture first hand, in my early 20’s. This partnership with Cansativa is about to be a powerful one, and I will be making a trip out to Germany for the launch this summer. I can’t express how ready I am to share our genetics with Germany.” – Gilbert Milam, Co-founder and CEO of Cookies, also known as rapper with stage name Berner.
“Working with Cansativa and Cookies, both heavy weights in the business, to bring Cookies to Germany is a huge milestone for RPK Biopharma and also signifies the deep commitment we have to produce the very best cannabis flower and products. The European cannabis market is at a tipping point with Germany having just announced decriminalization of cannabis. We’re excited to partner with Cansativa to bring one of the best-known cannabis brands in the world to patients in Germany” says Tom Flow, Managing Director of RPK Biopharma, a 100% subsidiary of SOMAÍ Group.
“SOMAÍ continues to support German patients by offering one of the most iconic flower brands Cookies through the Cansativa group,” says Michael Sassano, the Founder and Interim CEO of SOMAÍ Group.
About Cansativa Group
Cansativa Group was founded in 2017 by the brothers Benedikt and Jakob Sons in Frankfurt am Main, Germany. Cansativa has the largest platform for the most desirable cannabis products and brands which makes it the leader in the medical cannabis market. Through a network of around 2000 pharmacies, Cansativa currently supplies around 300,000 patients in Germany with medical cannabis in the context of pain therapies.
With regard to the reclassification of cannabis in Germany, the Cansativa Group sees itself as a pioneer in the democratization of the cannabis market. Cansativa has the necessary infrastructure and expertise to safely import, store, license, distribute and brand cannabis. The company is also committed to cannabis education. With the vision “We enable Cannabis”, Cansativa sees itself as a driving force of the cannabis industry in Germany.
For more information, visit www.cansativa.de/en.
About Cookies
Cookies is the most globally recognized cannabis company; founded in 2010 by Billboard-charting rapper and entrepreneur Berner and Bay Area breeder and cultivator Jai. The company creates game-changing genetics and offers a collection of over 70 proprietary cannabis cultivars and more than 2,000 products. Headquartered in San Francisco, the company is actively involved in advocacy and social impact initiatives to enrich communities disproportionately impacted by the War on Drugs. Cookies opened its first retail store in 2018 in Los Angeles, has since expanded to over 70 retail locations in over 20 markets across 6 countries, and was recently named one of America’s Hottest Brands of 2021 by Ad Age; the first cannabis brand to ever receive this accolade.
To learn more about Cookies, visit https://cookies.co/.
About SOMAÍ Group
SOMAÍ Group is a leading EU-GMP European biotech company with a global footprint of distribution for the largest and most advanced EU-GMP-certified cannabinoid-containing portfolio. At SOMAÍ, we are building a leading global brand with the most robust pipeline of innovative cannabis-based products.
SOMAÍ Group owns a state-of-the-art manufacturing facility SOMAÍ Pharmaceuticals and indoor cultivation RPK Biopharma in Lisbon, Portugal, and has global sales teams in the largest medical cannabis markets. We are continuing to make acquisitions and global brand partnerships that make us one of the few vertically integrated companies in the EU able to cater to the diverse needs of fast-growing European cannabis markets.
Press Contact Cansativa
Angela Koch
+49 (0)151 51067532 cansativa@schoesslers.com
Press Contact Cookies
Emily Meshell +1-318-564-8195 em@mygrasslands.com
Press Contact RPK Biopharma / SOMAÍ Group
Nataliia Garnina
hello@somaipharma.eu